Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-1785PMID 16585220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells.

  2005cited by this paper
• FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.

  2004cited by this paper
• Follicle-stimulating Hormone Activation of Hypoxia-inducible Factor-1 by the Phosphatidylinositol 3-Kinase/AKT/Ras Homolog Enriched in Brain (Rheb)/Mammalian Target of Rapamycin (mTOR) Pathway Is Necessary for Induction of Select Protein Markers of Follicular Differentiation*

  2004cited by this paper
• FSH activates phosphatidylinositol 3-kinase/protein kinase B signaling pathway in 20-day-old Sertoli cells independently of IGF-I.

  2004cited by this paper
• PI3K/Akt signalling pathway and cancer.

  2004cited by this paper
• Human Chorionic Gonadotropin Decreases Proliferation and Invasion of Breast Cancer MCF-7 Cells by Inhibiting NF-κB and AP-1 Activation*

  2004cited by this paper
• Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.

  2004cited by this paper
• Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells.

  2004cited by this paper
• Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.

  2003cited by this paper
• Luteinizing hormone increases human endometrial cancer cells invasiveness through activation of protein kinase A.

  2003cited by this paper
• Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells.

  2003cited by this paper
• Risk factors and risk reduction of breast and ovarian cancer

  2003cited by this paper
• Luteinizing hormone in peritoneal and ovarian cyst fluids: a predictor of ovarian carcinoma.

  2003cited by this paper
• Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.

  2002cited by this paper
• Gonadotropin stimulation of MLS human epithelial ovarian carcinoma cells augments cell adhesion mediated by CD44 and by alpha(v)-integrin.

  2002cited by this paper
• Plasminogen Activator Inhibitor-1 and -3 Increase Cell Adhesion and Motility of MDA-MB-435 Breast Cancer Cells*

  2002cited by this paper
• Characterization of human chorionic gonadotropin as a novel angiogenic factor.

  2002cited by this paper
• VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors

  2002cited by this paper
• Follicle-stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells.

  2002cited by this paper
• Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells.

  2001cited by this paper
• Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells.

  2001cited by this paper
• Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta.

  2001cited by this paper
• Effects of Human Chorionic Gonadotropin on Trophoblast Invasion

  2001cited by this paper
• Protein Kinase A Regulates Rac and Is Required for the Growth Factor-stimulated Migration of Carcinoma Cells*

  2001cited by this paper
• Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.

  2001influential reference
• High-dose progesterone inhibition of urokinase secretion and invasive activity by SKOV-3 ovarian carcinoma cells: evidence for a receptor-independent nongenomic effect on the plasma membrane.

  2001cited by this paper
• Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.

  2001cited by this paper
• Positive regulation of cell-cell and cell-substrate adhesion by protein kinase A.

  2001cited by this paper
• Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system.

  2001cited by this paper
• Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association.

  2001cited by this paper
• Diverse effects of FSH and LH on proliferation of human ovarian surface epithelial cells.

  2001cited by this paper
• Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer.

  2001cited by this paper
• Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use.

  2000cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.

  2000cited by this paper
• Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.

  1999cited by this paper
• Risk of cancer after use of fertility drugs with in-vitro fertilisation.

  1999cited by this paper
• Metastatic Dissemination of Human Ovarian Epithelial Carcinoma Is Promoted by α2β1-Integrin-Mediated Interaction with Type I Collagen

  1999cited by this paper
• Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin.

  1999influential reference
• Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation.

  1999cited by this paper
• Apoptosis of ovarian granulosa cells: Correlation with the reduced activity of ERK‐signaling module

  1999cited by this paper
• Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen.

  1998cited by this paper
• Follicle stimulating hormone (FSH) activates the p38 mitogen-activated protein kinase pathway, inducing small heat shock protein phosphorylation and cell rounding in immature rat ovarian granulosa cells.

  1998cited by this paper
• Epidemiology and risk assessment for ovarian cancer.

  1998cited by this paper
• Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

  1998cited by this paper
• The significance of urokinase‐type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer

  1995cited by this paper
• Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.

  1995cited by this paper
• Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.

  1994cited by this paper
• Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy.

  1990cited by this paper
• Letter: The etiology and prevention of ovarian cancer.

  1975cited by this paper
• The etiology and prevention of ovarian cancer

  1975cited by this paper

• Repurposing trifluoperazine as a potential therapeutic agent for ovarian cancer: mechanistic insight via SRC/PI3K/AKT signaling pathway inhibition.

  2026cites this paper
• Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery

  2024cites this paper
• Effects of luteinizing hormone receptor activation in immortalized neoplastic canine T lymphocytes.

  2024cites this paper
• DEAD-Box Helicase 4 (Ddx4)+ Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers

  2020cites this paper
• Complex roles of cAMP–PKA–CREB signaling in cancer

  2020cites this paper
• FSH Beyond Fertility

  2019cites this paper
• Ovarian Cancer Targeting Phage for In Vivo Near-Infrared Optical Imaging

  2019cites this paper
• Follicle ‐ stimulating hormone promoted pyruvate kinase isozyme type M 2 ‐ induced glycolysis and proliferation of ovarian cancer cells

  2019cites this paper
• Extragonadal FSHR Expression and Function—Is It Real?

  2019cites this paper
• Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells

  2019cites this paper
• The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression

  2018cites this paper
• Vascular Endothelial FSH Receptor, a Target of Interest for Cancer Therapy.

  2018cites this paper
• Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells.

  2017cites this paper
• Luteinizing hormone inhibits cisplatin-induced apoptosis in human epithelial ovarian cancer cells.

  2016cites this paper
• Follicle-stimulating hormone enhances alveolar bone resorption via upregulation of cyclooxygenase-2.

  2016cites this paper
• OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer.

  2015cites this paper
• Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation.

  2015cites this paper
• Original Article Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation

  2015cites this paper
• Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.

  2015cites this paper
• The role of reproductive hormones in epithelial ovarian carcinogenesis.

  2015cites this paper
• Membrane type-1 matrix metalloproteinase (MT1-MMP) as a target in cancer therapy.

  2014cites this paper
• Mechanoregulation of leading edge PKA activity during ovarian cancer cell migration

  2014cites this paper
• Follicle-Stimulating Hormone Induced Epithelial-Mesenchymal Transition of Epithelial Ovarian Cancer Cells Through Follicle-Stimulating Hormone Receptor PI3K/Akt-Snail Signaling Pathway

  2014cites this paper
• Amphiregulin induces human ovarian cancer cell invasion by down‐regulating E‐cadherin expression

  2014cites this paper
• Нарушения гемостаза и их профилактика низкомолекулярными гепаринами у онкологических больных

  2013cites this paper
• through a Nitric Oxide-Mediated Pathway Regulates Matrix Metalloproteinase-9 The Transcription Factor Wilms Tumor 1

  2013cites this paper
• Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway

  2013cites this paper
• Protein Kinase G-Iα Hyperactivation and VASP Phosphorylation in Promoting Ovarian Cancer Cell Migration and Platinum Resistance

  2013cites this paper
• FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3.

  2013cites this paper
• Identification of two novel, alternatively spliced mRNA transcripts of the human follicle‐stimulating hormone receptor

  2013cites this paper
• [Clinical prospects of tumor-associated proteases and their tissue inhibitors investigation in oncologic patient].

  2013cites this paper
• Downregulation of G3BPs inhibits the growth, migration and invasion of human lung carcinoma H1299 cells by suppressing the Src/FAK-associated signaling pathway

  2013cites this paper
• 17β-Oestradiol activates proteolysis and increases invasion through phosphatidylinositol 3-kinase pathway in human cervical cancer cells.

  2012cites this paper
• Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway.

  2012cites this paper
• Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancer

  2012cites this paper
• Gonadotropins Regulate Oncogenic Pathways in Ovarian Surface Epithelium in a Three-Dimensional Model

  2012cites this paper
• Activation of the PKC Pathway Stimulates Ovarian Cancer Cell Proliferation, Migration, and Expression of MMP7 and MMP101

  2012cites this paper
• Changes in gene expression for cytokines, growth factors and their receptors are associated with epithelial ovarian cancer

  2012cites this paper
• Gonadotropin signalling in epithelial ovarian cancer.

  2012cites this paper
• Epithelial ovarian cancer: A feasible plan for adjunctive treatment using simultaneous acyclovir, ambrisentan, captopril, disulfiram, fluvoxamine-augmented ramelteon, icatibant, imiquimod peritoneal lavage, and plerixafor

  2012cites this paper
• Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation

  2011cites this paper
• The mechanism of selective transfection mediated by pentablock copolymers; part I: investigation of cellular uptake.

  2011cites this paper
• Self-assembled pentablock copolymers for selective and sustained gene delivery

  2011cites this paper
• The Effects of the Female Reproductive Hormones on Ovarian Cancer Initiation and Progression in a Transgenic Mouse Model of the Disease

  2011cites this paper
• Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin‐1 receptor II: To a link between endometriosis and endometrioid ovarian cancer

  2011cites this paper
• Luteinizing hormone upregulates survivin and inhibits apoptosis in ovarian epithelial tumors.

  2011cites this paper
• Protein Kinase A Activity and Anchoring Are Required for Ovarian Cancer Cell Migration and Invasion

  2011cites this paper
• The luteinizing hormone receptor: insights into structure-function relationships and hormone-receptor-mediated changes in gene expression in ovarian cancer cells.

  2010cites this paper
• Cancer esearch apeutics , Targets , and Chemical Biology Is an Essential Factor and Therapeutic Target R Metastatic Ovarian Cancer

  2010cites this paper
• Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C{delta}.

  2010cites this paper
• Gonadotropins induce tumor cell migration and invasion by increasing cyclooxygenases expression and prostaglandin E(2) production in human ovarian cancer cells.

  2010influential citation
• AXL is an essential factor and therapeutic target for metastatic ovarian cancer.

  2010cites this paper
• Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix‐metalloproteinase expression

  2010cites this paper
• Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C.

  2009cites this paper
• Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo.

  2009cites this paper
• Overexpression of human sperm protein 17 increases migration and decreases the chemosensitivity of human epithelial ovarian cancer cells

  2009cites this paper
• Chorionic gonadotropin regulates prostaglandin E synthase via a phosphatidylinositol 3-kinase-extracellular regulatory kinase pathway in a human endometrial epithelial cell line: implications for endometrial responses for embryo implantation.

  2009cites this paper
• Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer.

  2009cites this paper
• Lysophosphatidic Acid Stimulates Cell Growth by Different Mechanisms in SKOV-3 and Caov-3 Ovarian Cancer Cells: Distinct Roles for Gi- and Rho-Dependent Pathways

  2009cites this paper
• Three-dimensional ovarian organ culture as a tool to study normal ovarian surface epithelial wound repair.

  2009cites this paper
• Molecular pathogenesis of borderline and invasive ovarian tumors.

  2009cites this paper
• Regulation of lysophospholipid signaling in development and cancer

  2009influential citation
• Basal and Oxidative Stress–Induced Expression of Metallothionein Is Decreased in Ascending Aortic Aneurysms of Bicuspid Aortic Valve Patients

  2009cites this paper
• Ovarian Epithelial Cancer: Etiology and Pathogenesis

  2008cites this paper
• Regulator of G-protein signalling expression and function in ovarian cancer cell lines

  2008cites this paper
• Concentrations of follicle stimulating hormone are increased in ovarian tumor fluid: implications for the management of ovarian cancer.

  2008cites this paper
• [Epithelial ovarian tumor microecology].

  2008cites this paper
• Rapid xenograft tumor progression in beta‐arrestin1 transgenic mice due to enhanced tumor angiogenesis

  2008cites this paper
• Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma

  2008cites this paper
• Gonadotropin‐releasing hormone and ovarian cancer: a functional and mechanistic overview

  2008cites this paper
• Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway.

  2008cites this paper
• Endothelial injury in cardiac transplantation : the role of endothelin antagonism and protein kinases.

  2008cites this paper
• Early alterations in ovarian surface epithelial cells and induction of ovarian epithelial tumors triggered by loss of FSH receptor.

  2007cites this paper
• Epithelial–mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm

  2007influential citation
• Gonadotropins and ovarian cancer.

  2007cites this paper
• The Transcription Factor Wilms Tumor 1 Regulates Matrix Metalloproteinase-9 through a Nitric Oxide-Mediated Pathway

  2007cites this paper
• Gonadotropin and its role in the β-catenin/T-cell factor signaling pathway

  2007cites this paper
• Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion

  2007cites this paper
• Role of endocrine and growth factors on the ovarian surface epithelium

  2007cites this paper
• Genetically engineered models have advantages over xenografts for preclinical studies.

  2006cites this paper